BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 28913971)

  • 1. Nanobodies: Chemical Functionalization Strategies and Intracellular Applications.
    Schumacher D; Helma J; Schneider AFL; Leonhardt H; Hackenberger CPR
    Angew Chem Int Ed Engl; 2018 Feb; 57(9):2314-2333. PubMed ID: 28913971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
    Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
    Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
    Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
    Front Immunol; 2021; 12():838082. PubMed ID: 35116045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells.
    Herce HD; Schumacher D; Schneider AFL; Ludwig AK; Mann FA; Fillies M; Kasper MA; Reinke S; Krause E; Leonhardt H; Cardoso MC; Hackenberger CPR
    Nat Chem; 2017 Aug; 9(8):762-771. PubMed ID: 28754949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast surface display platform for rapid discovery of conformationally selective nanobodies.
    McMahon C; Baier AS; Pascolutti R; Wegrecki M; Zheng S; Ong JX; Erlandson SC; Hilger D; Rasmussen SGF; Ring AM; Manglik A; Kruse AC
    Nat Struct Mol Biol; 2018 Mar; 25(3):289-296. PubMed ID: 29434346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development.
    Li B; Qin X; Mi LZ
    Nanoscale; 2022 May; 14(19):7110-7122. PubMed ID: 35535618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering.
    Verkhivker G
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Selective Functionalization of Nanobodies Using Intein-Mediated Protein Ligation for Innovative Bioconjugation.
    Graulus GJ; Ta DT; Tran H; Hansen R; Billen B; Royackers E; Noben JP; Devoogdt N; Muyldermans S; Guedens W; Adriaensens P
    Methods Mol Biol; 2019; 2033():117-130. PubMed ID: 31332751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression cloning of camelid nanobodies specific for Xenopus embryonic antigens.
    Itoh K; Sokol SY
    PLoS One; 2014; 9(10):e107521. PubMed ID: 25285446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobodies as molecular imaging probes.
    Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
    Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of nanobodies in plant science and biotechnology.
    Wang W; Yuan J; Jiang C
    Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.
    Ta DT; Redeker ES; Billen B; Reekmans G; Sikulu J; Noben JP; Guedens W; Adriaensens P
    Protein Eng Des Sel; 2015 Oct; 28(10):351-63. PubMed ID: 26243885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change of Amino Acid Residues in Idiotypic Nanobodies Enhanced the Sensitivity of Competitive Enzyme Immunoassay for Mycotoxin Ochratoxin A in Cereals.
    Zhang C; Zhang W; Tang X; Zhang Q; Zhang W; Li P
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32340239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies.
    Zuo J; Li J; Zhang R; Xu L; Chen H; Jia X; Su Z; Zhao L; Huang X; Xie W
    BMC Genomics; 2017 Oct; 18(1):797. PubMed ID: 29041922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobodies Right in the Middle: Intrabodies as Toolbox to Visualize and Modulate Antigens in the Living Cell.
    Wagner TR; Rothbauer U
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33371447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming nanobodies into high-precision tools for protein function analysis.
    Gettemans J; De Dobbelaer B
    Am J Physiol Cell Physiol; 2021 Feb; 320(2):C195-C215. PubMed ID: 33264078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and Characterization Strategies for Nanobodies Targeting Membrane Proteins.
    Veugelen S; Dewilde M; De Strooper B; Chávez-Gutiérrez L
    Methods Enzymol; 2017; 584():59-97. PubMed ID: 28065273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ModiBodies: A computational method for modifying nanobodies in nanobody-antigen complexes to improve binding affinity and specificity.
    Hacisuleyman A; Erman B
    J Biol Phys; 2020 Jun; 46(2):189-208. PubMed ID: 32418062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.